Literature DB >> 12673743

Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.

G P Boland1, K C Chan, W F Knox, S A Roberts, N J Bundred.   

Abstract

BACKGROUND: The Van Nuys Prognostic Index (VNPI), an algorithm based on tumour size, tumour grade, presence of necrosis and excision margin width, is claimed to predict local recurrence after breast-conserving surgery for ductal carcinoma in situ (DCIS). The aim of this study was to examine the validity of the VNPI in a UK population.
METHODS: Clinicopathological data, including VNPI subgroups, for 237 patients who had breast-conserving operations for DCIS were examined. Multivariate data analysis was performed using a Cox regression model to examine the independence and relative importance of different variables in predicting recurrence, and to compare the data with those used in derivation of the VNPI.
RESULTS: The median follow-up was 47 months. There were 37 ipsilateral local recurrences. Excision margin width (P < 0.001) and tumour grade (by Van Nuys grading (P = 0.014) or simple nuclear grading (P = 0.004)) were the only independent risk factors for local recurrence. Excision margin width had three times more power than grade in predicting local recurrence. Subgrouping data by VNPI score predicted recurrence-free survival (P < 0.001), but stratified 78 per cent of patients into a group with a moderate risk of local recurrence.
CONCLUSION: Excision margin width is the most important predictor of local recurrence after breast-conserving surgery for DCIS. The VNPI lacked discriminatory power for guiding further patient management. Copyright 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12673743     DOI: 10.1002/bjs.4051

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  17 in total

1.  Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression.

Authors:  Paul Macklin; Mary E Edgerton; Alastair M Thompson; Vittorio Cristini
Journal:  J Theor Biol       Date:  2012-02-09       Impact factor: 2.691

2.  A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma In Situ.

Authors:  Michael S Toss; Guanhao Wei; Jaspreet Kaur; Karuna Mittal; Da Hoon Choi; Brian D Melton; Remus M Osan; Islam M Miligy; Andrew R Green; Emiel A M Janssen; Håvard Søiland; Keerthi Gogineni; Upender Manne; Padmashree Rida; Emad A Rakha; Ritu Aneja
Journal:  Clin Cancer Res       Date:  2020-01-14       Impact factor: 12.531

Review 3.  Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ.

Authors:  Tatyana Shamliyan; Shi-Yi Wang; Beth A Virnig; Todd M Tuttle; Robert L Kane
Journal:  J Natl Cancer Inst Monogr       Date:  2010

Review 4.  Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature Review.

Authors:  Renée S J M Schmitz; Erica A Wilthagen; Frederieke van Duijnhoven; Marja van Oirsouw; Ellen Verschuur; Thomas Lynch; Rinaa S Punglia; E Shelley Hwang; Jelle Wesseling; Marjanka K Schmidt; Eveline M A Bleiker; Ellen G Engelhardt
Journal:  Cancers (Basel)       Date:  2022-07-02       Impact factor: 6.575

Review 5.  Ductal Carcinoma In Situ of the Breast: Evaluating the Role of Radiation Therapy in the Management and Attempts to Identify Low-risk Patients.

Authors:  Chirag Shah; Frank A Vicini; Sameer Berry; Thomas B Julian; John Ben Wilkinson; Simona F Shaitelman; Atif Khan; Steven E Finkelstein; Neal Goldstein
Journal:  Am J Clin Oncol       Date:  2015-10       Impact factor: 2.339

Review 6.  The role of radiotherapy in the conservative treatment of ductal carcinoma in situ of the breast.

Authors:  Csaba Polgár; Zsuzsanna Kahán; Zsolt Orosz; Gabriella Gábor; Janaki Hadijev; Gábor Cserni; Janina Kulka; Nóra Jani; Zoltán Sulyok; György Lázár; Gábor Boross; Csaba Diczházi; Eva Szabó; Zsolt László; Zoltán Péntek; Tibor Major; János Fodor
Journal:  Pathol Oncol Res       Date:  2008-04-26       Impact factor: 3.201

Review 7.  Radiotherapy of Ductal Carcinoma In Situ.

Authors:  David Krug; Rainer Souchon
Journal:  Breast Care (Basel)       Date:  2015-08-19       Impact factor: 2.860

8.  Patient Experiences and Clinician Views on the Role of Radiation Therapy for Ductal Carcinoma In Situ.

Authors:  Dean A Shumway; Chandler M McLeod; Monica Morrow; Yun Li; Allison W Kurian; Aaron Sabolch; Ann S Hamilton; Kevin C Ward; Steven J Katz; Sarah T Hawley; Reshma Jagsi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-01-09       Impact factor: 8.013

9.  Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience.

Authors:  B Cutuli; C Lemanski; A Fourquet; B de Lafontan; S Giard; A Meunier; R Pioud-Martigny; F Campana; H Marsiglia; S Lancrenon; E Mery; F Penault-Llorca; E Fondrinier; C Tunon de Lara
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640

10.  Mammary carcinoma behavior is programmed in the precancer stem cell.

Authors:  Patrizia Damonte; J Graeme Hodgson; Jane Qian Chen; Lawrence J T Young; Robert D Cardiff; Alexander D Borowsky
Journal:  Breast Cancer Res       Date:  2008-06-03       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.